非酒精性脂肪性肝病中的脂质区带分布与磷脂重塑
该研究利用非酒精性脂肪肝(NAFL)和非酒精性脂肪性肝炎(NASH)的饮食与遗传小鼠模型,并借助先进质谱成像技术将结果转化至人类,分析肝组织脂质的空间分布与疾病进展的关系。研究发现对照组和NAFL样本中多种脂质呈 distinct 区带分布,NASH中脂质区带分布部分至完全丧失;同时磷脂膜重塑、花生四烯酸(AA)释放及促炎类花生酸生成相关基因表达增加,免疫组化提示重塑酶LPCAT2的区带位置可能参与AA脂质空间分布改变。结论认为NAFLD不仅与脂质富集有关,还涉及特定脂质及其代谢通路的区带变化,可能参与NAFLD的异质性发展。
要点
- NAFL和NASH小鼠模型及人类肝组织质谱成像显示,NASH中脂质区带分布部分至完全丧失。
- NASH中磷脂膜重塑、AA释放及促炎类花生酸生成相关基因表达增加。
- 免疫组化提示LPCAT2的区带位置可能参与AA脂质空间分布改变。
核心结论
- NAFLD不仅与脂质富集有关,还与特定脂质及其相关代谢通路的区带变化有关,这可能参与NAFLD的异质性发展。
研究设计与样本
- 研究使用NAFL和NASH的饮食与遗传小鼠模型,并借助先进质谱成像技术将结果转化至人类,关联肝组织脂质空间分布与疾病进展。
主要发现
- 在对照组和NAFL样本中鉴定出多种具有 distinct 区带分布的脂质,并在NASH中观察到脂质区带分布部分至完全丧失。
- NASH中磷脂膜重塑、花生四烯酸(AA)从膜释放及促炎和细胞损伤类花生酸生成相关基因的肝脏表达增加。
- 免疫组化分析提示重塑酶LPCAT2的区带位置参与含AA脂质的空间分布改变。
- 该过程形成中心周围肝细胞AA富集、膜释放AA及生成促炎类花生酸的循环,可能解释NASH中心周围区域氧化损伤增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) can progress from simple steatosis (i.e., nonalcoholic fatty liver [NAFL]) to nonalcoholic steatohepatitis (NASH), cirrhosis, and cancer. Currently, the driver for this progression is not fully understood; in particular, it is not known how NAFLD and its early progression affects the distribution of lipids in the liver, producing lipotoxicity and inflammation. In this study, we used dietary and genetic mouse models of NAFL and NASH and translated the results to humans by correlating the spatial distribution of lipids in liver tissue with disease progression using advanced mass spectrometry imaging technology. We identified several lipids with distinct zonal distributions in control and NAFL samples and observed partial to complete loss of lipid zonation in NASH. In addition, we found increased hepatic expression of genes associated with remodeling the phospholipid membrane, release of arachidonic acid (AA) from the membrane, and production of eicosanoid species that promote inflammation and cell injury. The results of our immunohistochemistry analyses suggest that the zonal location of remodeling enzyme LPCAT2 plays a role in the change in spatial distribution for AA-containing lipids. This results in a cycle of AA-enrichment in pericentral hepatocytes, membrane release of AA, and generation of proinflammatory eicosanoids and may account for increased oxidative damage in pericentral regions in NASH. CONCLUSION: NAFLD is associated not only with lipid enrichment, but also with zonal changes of specific lipids and their associated metabolic pathways. This may play a role in the heterogeneous development of NAFLD. (Hepatology 2017;65:1165-1180).
引用
- Hall Z, Bond NJ, Ashmore T, et al. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology. 2017. PMID: 27863448. doi:10.1002/hep.28953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。